Document is current
Any future updates will be listed below
-
Authors
Henes, Jörg https://orcid.org/0000-0002-8385-6861
Richter, Jutta G. https://orcid.org/0000-0001-8194-3243
Thiele, Katja https://orcid.org/0000-0003-1655-0595
Kiltz, Uta https://orcid.org/0000-0001-5668-4497
Callhoff, Johanna https://orcid.org/0000-0002-3923-2728
Albrecht, Katinka https://orcid.org/0000-0003-0886-0294
-
Funding
Funding for this research was provided by:
Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
- License Information
-
More Information
Article History
Received: 20 October 2023
Accepted: 8 November 2023
First Online: 5 January 2024
Declarations
:
: JR, KT and KA declared none. JH has received speaker fees from Abbvie, Amgen, Chugai/Roche, Janssen, Novartis and UCB. JC has received speaker fees from Janssen, Pfizer and Idorsia. UK has received grant and research support and consultancy fees from AbbVie, Amgen, Biocad, Biogen, Chugai, Eli Lilly, Fresenius, Gilead, Grünenthal, GSK, Janssen, MSD, Novartis, Pfizer, Roche and UCB.
